Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Zernig, G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 28 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ratzenboeck, E; Saria, A; Kriechbaum, N; Zernig, G
      Reinforcing effects of MDMA ('ecstasy') in drug-naive and cocaine-trained rats

      PHARMACOLOGY
    2. Oittinen, H; Rameis, H; Saria, A; Zernig, G
      Lack of reinforcing effect of the benzodiazepine and tricyclic antidepressant combination of diazepam and dothiepin

      PHARMACOLOGY
    3. Acquas, E; Marrocu, P; Pisanu, A; Cadoni, C; Zernig, G; Saria, A; Di Chiara, G
      Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo

      EUROPEAN JOURNAL OF PHARMACOLOGY
    4. Fischer, HS; Zernig, G; Schatz, DS; Humpel, C; Saria, A
      MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum

      EUROPEAN JOURNAL OF NEUROSCIENCE
    5. Fischer, HS; Zernig, G; Schuligoi, R; Miczek, KA; Hauser, KF; Gerard, C; Saria, A
      Alterations within the endogenous opioid system in mice with targeted deletion of the neutral endopeptidase ('enkephalinase') gene

      REGULATORY PEPTIDES
    6. Zernig, G; Saria, A; Krassnig, R; Schmidhammer, H
      Signal transduction efficacy of the highly potent mu opioid agonist 14-methoxymetopon

      LIFE SCIENCES
    7. Siems, WE; Maul, B; Krause, W; Gerard, C; Hauser, KF; Hersh, LB; Fischer, HS; Zernig, G; Saria, A
      Neutral endopeptidase and alcohol consumption, experiments in neutral endopeptidase-deficient mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    8. Koek, W; Assie, MB; Zernig, G; France, CP
      In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats

      PSYCHOPHARMACOLOGY
    9. Zernig, G; Saria, A
      Agonist promiscuity: a positive twist

      TRENDS IN PHARMACOLOGICAL SCIENCES
    10. BUTELMAN ER; KO MC; SOBCZYKKOJIRO K; MOSBERG HI; VANBEMMEL B; ZERNIG G; WOODS JH
      KAPPA-OPIOID RECEPTOR-BINDING POPULATIONS IN RHESUS-MONKEY BRAIN - RELATIONSHIP TO AN ASSAY OF THERMAL ANTINOCICEPTION

      The Journal of pharmacology and experimental therapeutics
    11. TABER MT; ZERNIG G; FIBIGER HC
      OPIOID RECEPTOR MODULATION OF FEEDING-EVOKED DOPAMINE RELEASE IN THE RAT NUCLEUS-ACCUMBENS

      Brain research
    12. WALKER EA; ZERNIG G; YOUNG AM
      IN-VIVO APPARENT AFFINITY AND EFFICACY ESTIMATES FOR MU-OPIATES IN A RAT TAIL-WITHDRAWAL ASSAY

      Psychopharmacology
    13. ZERNIG G; FIBIGER HC
      ACUTE AND PROLONGED EFFECTS OF CLOCINNAMOX AND METHOCLOCINNAMOX ON NUCLEUS-ACCUMBENS DOPAMINE OVERFLOW

      Psychopharmacology
    14. ZERNIG G; OLAUGHLIN IA; FIBIGER HC
      NICOTINE AND HEROIN AUGMENT COCAINE-INDUCED DOPAMINE OVERFLOW IN NUCLEUS-ACCUMBENS

      European journal of pharmacology
    15. ZERNIG G; FABISCH K; FABISCH H
      PHARMACOTHERAPY OF ALCOHOL DEPENDENCE

      Trends in pharmacological sciences
    16. ZERNIG G; LEWIS JW; WOODS JH
      CLOCINNAMOX INHIBITS THE INTRAVENOUS SELF-ADMINISTRATION OF OPIOID AGONISTS IN RHESUS-MONKEYS - COMPARISON WITH EFFECTS ON OPIOID AGONIST-MEDIATED ANTINOCICEPTION

      Psychopharmacology
    17. ZERNIG G; ISSAEVITCH T; WOODS JH
      CALCULATION OF AGONIST EFFICACY, APPARENT AFFINITY, AND RECEPTOR POPULATION-CHANGES AFTER ADMINISTRATION OF INSURMOUNTABLE ANTAGONISTS - COMPARISON OF DIFFERENT ANALYTICAL APPROACHES

      Journal of pharmacological and toxicological methods
    18. ZERNIG G; BURKE T; LEWIS JW; WOODS JH
      MECHANISM OF CLOCINNAMOX BLOCKADE OF OPIOID RECEPTORS - EVIDENCE FROMIN-VITRO AND EX-VIVO BINDING AND BEHAVIORAL ASSAYS

      The Journal of pharmacology and experimental therapeutics
    19. ZERNIG G; ISSAEVITCH T; BROADBEAR JH; BURKE TF; LEWIS JW; BRINE GA; WOODS JH
      RECEPTOR RESERVE AND AFFINITY OF MU-OPIOID AGONISTS IN MOUSE ANTINOCICEPTION - CORRELATION WITH RECEPTOR-BINDING

      Life sciences
    20. WALKER EA; ZERNIG G; WOODS JH
      BUPRENORPHINE ANTAGONISM OF MU-OPIOIDS IN THE RHESUS-MONKEY TAIL-WITHDRAWAL PROCEDURE

      The Journal of pharmacology and experimental therapeutics
    21. BUTELMAN ER; WINGER G; ZERNIG G; WOODS JH
      BUTORPHANOL - CHARACTERIZATION OF AGONIST AND ANTAGONIST EFFECTS IN RHESUS-MONKEYS

      The Journal of pharmacology and experimental therapeutics
    22. ZERNIG G; BURKE T; LEWIS JW; WOODS JH
      CLOCINNAMOX BLOCKS ONLY MU-RECEPTORS IRREVERSIBLY - BINDING EVIDENCE

      Regulatory peptides
    23. ZERNIG G; BUTELMAN ER; LEWIS J; WOODS JH
      IN-VIVO DETERMINATION OF MU-OPIOID RECEPTOR RESERVE AND TURNOVER IN RHESUS-MONKEYS AFTER IRREVERSIBLE BLOCKADE WITH CLOCINNAMOX

      Regulatory peptides
    24. ZERNIG G; BUTELMAN ER; LEWIS JW; WALKER EA; WOODS JH
      IN-VIVO DETERMINATION OF MU-OPIOID RECEPTOR TURNOVER IN RHESUS-MONKEYS AFTER IRREVERSIBLE BLOCKADE WITH CLOCINNAMOX

      The Journal of pharmacology and experimental therapeutics
    25. SARIA A; TROGER J; ZERNIG G
      DIFFERENT BEHAVIORAL PROFILES OF THE NONPEPTIDE SUBSTANCE-P (NK-1) ANTAGONISTS CP-96,345 AND RP-67580

      Regulatory peptides
    26. ZERNIG G
      HOW MANY TREES DID YOU KILL TODAY

      Lancet
    27. ZERNIG G
      ADVICE FROM A SEASONED CONGRESS TOURIST

      Lancet
    28. ZERNIG G; REIDER N
      ION DEPENDENCE OF THE PARTIALLY PURIFIED MITOCHONDRIAL DIHYDROPYRIDINE CA2+ ANTAGONIST RECEPTOR

      Molecular pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 17:58:34